The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
Celsion Corp (CLSN)

Celsion is a clinical stage biotechnology company focused on developing a portfolio of treatments including DNA-based immunotherapies, vaccines and chemotherapies. Co.'s product pipeline includes GEN-1, a DNA-based immunotherapy for ovarian cancer treatment and ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is under investigator-sponsored development for several cancer indications. Co. has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies and vaccines and other anti-cancer DNA or RNA therapies. Both are synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection.

Company Name:  Celsion Corp
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding CLSN:  4
Total Market Value Held by ETFs:  $1.50M
Total Market Capitalization:  $34.00M
% of Market Cap. Held by ETFs:  4.40%
January 25, 2022    11:49 AM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree CLSN Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.00 out of 4)
18th percentile
(ranked lower than approx. 82% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Celsion Corp (CLSN) Page | The Online Investor | | Copyright © 1998 - 2022, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.